Hitchhiking cancer vaccine makes progress in the clinic
MIT spinout Elicio developed a vaccine based on a lymph node-targeting approach first developed at the Koch Institute. Phase 1 solid tumor clinical trial results are promising so far.
Bendta Schroeder | Koch Institute •
mit
Feb. 15, 2024 • ~11 min
Feb. 15, 2024 • ~11 min
MIT-led team receives funding to pursue new treatments for metabolic disease
Awarded $65.67 million from ARPA-H, the researchers will work to develop ingestible capsules that deliver mRNA and electric stimuli to treat metabolic disorders such as diabetes.
Anne Trafton | MIT News •
mit
Feb. 5, 2024 • ~6 min
Feb. 5, 2024 • ~6 min
Significant gaps in COVID-19 vaccine uptake may have led to over 7,000 hospitalisations and deaths
Between a third and a half of the populations of the four UK nations had not had the recommended number of COVID vaccinations and boosters by summer 2022,
Cambridge University News •
cambridge
Jan. 15, 2024 • ~5 min
Jan. 15, 2024 • ~5 min
Rabies is an ancient, unpredictable and potentially fatal disease − two rabies researchers explain how to protect yourself
An unexpected case of rabies found in an animal can raise concerns for a potential outbreak. Proactive vaccination of both wildlife and people can help protect everyone.
Charles Rupprecht, Affiliate Professor of Veterinary Medicine, Auburn University •
conversation
Jan. 9, 2024 • ~10 min
Jan. 9, 2024 • ~10 min
/
81